Important Notice: All grants and sponsorships must be submitted in NGCS by October 1, 2026, before the system closes to new submissions. Submissions received by this date will receive a full review in NGCS. The new platform is scheduled to launch on November 16, 2026.
Novartis is reimagining medicine to improve and extend people’s lives. We provide financial support for educational, advocacy and outreach activities that help advance our goals of improving patient and public health.
Important Notice: All grants and sponsorships must be submitted in NGCS by October 1, 2026, before the system closes to new submissions. Submissions received by this date will receive a full review in NGCS. The new platform is scheduled to launch on November 16, 2026.
Novartis provides grants to US organizations to support medical education for US Healthcare Professionals (HCPs) and patient education initiatives in the US.
Important Notice: All grants and sponsorships must be submitted in NGCS by October 1, 2026, before the system closes to new submissions. Submissions received by this date will receive a full review in NGCS. The new platform is scheduled to launch on November 16, 2026.
Novartis provides funding – through sponsorships and memberships – to US nonprofit healthcare or healthcare-related organizations for activities and events in the US that support our goals in improving public health.
Please carefully read all the information about our educational grants, sponsorships and memberships before you submit your application through the online portal.
| Professional Medical Education/Sponsorships | |
|---|---|
| Non-Oncology & Oncology Email: [email protected] | |
| Patient Advocacy/Education | |
|---|---|
| Non-Oncology Email: [email protected] | Oncology Email: [email protected] |
Disclaimer
Please do not consider any request approved until you have received written documentation from Novartis that your application has been approved for funding and all of the required paperwork, including a counter-signed original Letter of Agreement, has been received by you. Any expenses incurred prior to receiving written support of the program by Novartis are taken at your own risk.
Previous support by Novartis does NOT guarantee future support as each request is evaluated on individual merit. If you have any questions, please contact a member of the US Professional Medical Education or Patient Advocacy Teams. Please do NOT contact your sales representative, medical science liaison, regional scientific director, or marketing personnel regarding the status of a request.
Novartis will review each submission in a timely manner. Your prompt response to requests for any additional information is critical to this process and appreciated.
Novartis is aware of the growing need for education and support for the medical and patient/caregiver communities. Many more requests are received than can be funded and we regret that we cannot accommodate every request. However, your submission will receive a fair and thorough review. In return, please take time to consider how your program fits within the therapeutic areas of interest for Novartis and the established regulations, laws and guidelines before submitting a request.